Co-amoxiclav jaundice: Clinical and histological features and HLA class II association

Gut

Volumn 47, Issue 5, 2000, Pages 717-720

  O'Donohue, J ^a   Oien, K A ^b   Donaldson, P ^c   Underhill, J ^c   Clare, M ^c   MacSween, R N M ^b   Mills, P R ^a  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Co amoxiclav; Human leucocyte antigen; Jaundice

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADULT; AGED; ARTICLE; BILIARY CIRRHOSIS; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG RESPONSE; FEMALE; FOLLOW UP; HAPLOTYPE; HEREDITY; HISTOLOGY; HUMAN; JAUNDICE; LIVER BIOPSY; LIVER TOXICITY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; BILIRUBIN; BIOPSY; CASE-CONTROL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HAPLOTYPES; HLA-D ANTIGENS; HUMANS; JAUNDICE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE PROBES; POLYMERASE CHAIN REACTION;

EID: 0033756344     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.47.5.717     Document Type: Article

References (26)

1. Cholestatic hepatitis due to amoxicillin and clavulanic acid
2. Augmentin-induced jaundice with a fatal outcome
3. Augmentin-induced hepatorenal failure and death
4. HLA association of amoxicillin-clavulanate-induced hepatitis
5. Criteria of drug-induced liver disorders: Report of an international consensus meeting
6. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia
7. HLA and disease associations: Detecting the strongest association
8. Cholestatic jaundice with co-amoxiclav
9. Hepatitis associated with amoxycillin-clavulanic acid: Combination report of 15 cases
10. Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid
11. Revised indications for co-amoxiclav (Augmentin)
12. Liver injury related to amoxycillin-clavulanic acid: Interlobular bile-duct lesions and extrahepatic manifestations
13. Amoxicillin-clavulanate potassium-associated cholestasis
14. Focal destructive cholangiopathy associated with amoxycillin/clavulanic acid (Augmentin)
15. Vanishing bile duct syndrome after amoxicillin/clavulanic acid (A/CA)
16. Immunohistochemical analysis of adhesion molecules in the microenvironment of portal tracts in relation to aberrant expression of PDC-E2 and HLA-DR on the bile ducts in primary biliary cirrhosis
17. Genes within the HLA class II region confer both predisposition and resistance to primarybiliary cirrhosis
18. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis
19. Hepatic injury associated with the use of nitrofurans: A clinicopathological study of 52 reported cases
20. HLA antigens in patients with unexplained hepatitis following halothane anaesthesia
21. HLA-DR2, [HLA-B7, SC31, DR2], and [HLA-B8, SC01, DR3] haplotypes distinguish subjects with asthma from those with rhinitis only in ragweed pollen allergy
22. Allergy to antibiotics; T cell recognition of amoxicillin is HLA-DR restricted and does not require antigen processing
23. Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid
24. Intrahepatic cholestasis due to ticarcillin-clavulanate